Presentation ( PDF 2.35 MB )
Make
it Intact
Q2-2022 Review of Performance
|
Page 2 | |
Q2-2022 Review of Performance |
Forward-looking statements
Certain of the statements included in this presentation about the Company's current and future plans, expectations and intentions, results, levels of activity, performance, goals or achievements or any other future events or developments constitute forward-looking statements. The words "may", "will", "would", "should", "could", "expects", "plans", "intends", "trends", "indications", "anticipates", "believes", "estimates", "predicts", "likely", "potential" or the negative or other variations of these words or other similar or comparable words or phrases, are intended to identify forward-looking statements. Unless otherwise indicated, all forward-looking statements in this presentation are made as at
Forward-looking statements are based on estimates and assumptions made by management based on management's experience and perception of historical trends, current conditions and expected future developments, as well as other factors that management believes are appropriate in the circumstances. In addition to other estimates and assumptions which may be identified herein, estimates and assumptions have been made regarding, among other things, the realization of the expected strategic, financial and other benefits of the RSA Acquisition, the Sale of
- expected regulatory processes and outcomes in connection with its business;
- government regulations designed to protect policyholders and creditors rather than investors;
- the occurrence and frequency of catastrophe events, including a major earthquake;
- catastrophe losses caused by severe weather and other weather-related losses, as well as the impact of climate change;
- intense competition and disruption;
- unfavourable capital market developments or other factors, including the impact of the COVID-19 pandemic and related economic conditions, which may affect the Company's investments, floating rate securities and funding obligations under its pension plans;
- the Company's ability to implement its strategy or operate its business as management currently expects;
- its ability to accurately assess the risks associated with the insurance policies that the Company writes;
- the Company's ability to otherwise complete the integration of the business acquired within anticipated time periods and at expected cost levels, as well as its ability to operate in new jurisdictions relating to the RSA Acquisition;
- the Company's ability to achieve synergies arising from successful integration plans relating to acquisitions;
- the Company's reliance on information technology and telecommunications systems and potential failure of or disruption to those systems, including in the context of the impact on the ability of our workforce to perform necessary business functions remotely, as well as in the context of evolving cybersecurity risk;
- the impact of developments in technology and use of data on the Company's products and distribution;
- the Company's ability to contain fraud and/or abuse;
- periodic negative publicity regarding the insurance industry;
- the Company's reliance on brokers and third parties to sell its products to clients and provide services to the Company, and the impact of COVID-19 and related economic conditions on such brokers and third parties;
- the occurrence of and response to public health crises including epidemics, pandemics or outbreaks of new infectious diseases, including, most recently, the COVID-19 pandemic and ensuing events;
- the volatility of the stock market and other factors affecting the trading prices of the Company's securities, including in the context of the COVID-19 economic crisis;
- litigation and regulatory actions, including with respect to the COVID-19 pandemic;
- changes in laws or regulations, including those adopted in response to COVID-19 that would, for example, require insurers to cover business interruption claims irrespective of terms after policies have been issued, and could result in an unexpected increase in the number of claims and have a material adverse impact on the Company's financial results;
- COVID-19related coverage issues and claims, including certain class actions and related defence costs, could negatively impact our claims reserves;
- terrorist attacks and ensuing events;
- the Company's ability to maintain its financial strength and issuer credit ratings;
- the Company's access to debt and equity financing;
- the Company's ability to compete for large commercial business;
- the Company's ability to alleviate risk through reinsurance;
- the Company's ability to successfully manage credit risk (including credit risk related to the financial health of reinsurers);
- the Company's dependence on and ability to retain key employees;
- the cyclical nature of the P&C insurance industry;
- management's ability to accurately predict future claims frequency and severity
- ,
- the Company's ability to successfully pursue its acquisition strategy;
- the Company's ability to execute its business strategy;
- management's estimates and expectations in relation to future economic and business conditions and other factors in relation to the Sale of
Middle East and the Sale and resulting impact on growth and accretion in various financial metrics; - the Company's ability to improve its combined ratio, retain existing and attract new business, attract and retain key employees with the in-depth knowledge and necessary skills, maintain market position arising from successful integration plans relating to the RSA Acquisition, as well as management's estimates and expectations in relation to future economic and business conditions and other factors in relation to the RSA Acquisition and resulting impact on growth and accretion in various financial metrics;
- the Company's participation in the
Facility Association (a mandatory pooling arrangement among all industry participants) and similar mandated risk-sharing pools; - general economic, financial and political conditions;
- the Company's dependence on the results of operations of its subsidiaries and the ability of the Company's subsidiaries to pay dividends;
- the Company's ability to hedge exposures to fluctuations in foreign exchange rates;
- future sales of a substantial number of its common shares;
- the Company's ability to meet its net zero carbon emission targets; and
- changes in applicable tax laws, tax treaties or tax regulations or the interpretation or enforcement thereof.
All of the forward-looking statements included in this presentation, the MD&A and the quarterly earnings press release dated
|
Page 3 | |
Q2-2022 Review of Performance |
Disclaimer
This presentation does not constitute or form part of any offer for sale or solicitation of any offer to buy or subscribe for any securities nor shall it or any part of it form the basis of or be relied on in connection with, or act as any inducement to enter into, any contract or commitment whatsoever.
The information contained in this presentation concerning the Company does not purport to be all-inclusive or to contain all the information that a prospective purchaser or investor may desire to have in evaluating whether or not to make an investment in the Company. The information is qualified entirely by reference to the Company's publicly disclosed information.
No representation or warranty, express or implied, is made or given by or on behalf of the Company or any of its the directors, officers or employees as to the accuracy, completeness or fairness of the information or opinions contained in this presentation and no responsibility or liability is accepted by any person for such information or opinions. In furnishing this presentation, the Company does not undertake or agree to any obligation to provide the attendees with access to any additional information or to update this presentation or to correct any inaccuracies in, or omissions from, this presentation that may become apparent. The information and opinions contained in this presentation are provided as at the date of this presentation. The contents of this presentation are not to be construed as legal, financial or tax advice. Each prospective purchaser should contact his, her or its own legal adviser, independent financial adviser or tax adviser for legal, financial or tax advice.
Non-GAAP and Other Financial Measures
We use both Generally Accepted Accounting Principles (GAAP) financial measures ("reported measures"), as well as Non-GAAP financial measures and Non-GAAP ratios (each as defined in National Instrument 52-112"Non-GAAP and Other Financial Measures Disclosure") to assess our performance. Non-GAAP financial measures and Non-GAAP ratios (which are calculated using Non-GAAP financial measures) do not have standardized meanings prescribed by IFRS and may not be comparable to similar measures used by other companies in our industry.
The Non-GAAP financial measures included in the MD&A and other financial reports are: operating DPW, operating NPW, operating NEP, operating net claims, operating net underwriting expenses, underwriting income, operating net investment income, distribution income, total finance costs, other operating income (expense), operating and total income tax expense (benefit), PTOI, NOI, NOI attributable to common shareholders, pre-tax income, non-operating results, adjusted net income, adjusted average common shareholder's equity, adjusted average common shareholder's equity (excluding AOCI), debt outstanding (excluding hybrid debt), debt outstanding and preferred shares (including NCI) and adjusted total capital.
The Non-GAAP ratios included in the presentation and other financial reports (other than Consolidated financial statements) are:
- operating growth and operating growth in constant currency (for both operating DPW and NPW);
- operating NEP growth and operating NEP growth in constant currency;
- operating combined ratio, claims ratio (including underlying current year loss ratio, CAT loss ratio and PYD ratio) and expense ratio (including commissions ratio, general expenses ratio and premium taxes ratio);
- operating and total effective income tax rates;
- NOIPS and AEPS, as well as ROE, OROE and AROE;
- book value per share (BVPS) excluding AOCI; and adjusted debt-to-total capital ratio and total leverage ratio.
We believe that similar measures and ratios are widely used in the industry and provide investors, financial analysts, rating agencies and other stakeholders with a better understanding of our business activity and financial results over time, in line with how management analyses performance. Non-GAAP and other financial measures used by management are fully defined and reconciled to the corresponding GAAP measures. We also use other financial measures to assess our performance, including supplementary financial measures and segment measures, which are further presented in the MD&A.
See Section 19 - Non-GAAP and other financial measures of the Q2-2022 MD&A for the definition and reconciliation to the most comparable GAAP measures (or "reported measures").
Important notes:
- Abbreviations and definitions of selected key terms used in this presentation are defined in Section 23 -Glossary and definitions of our Q2-2022 MD&A
- Other insurance-related terms are defined in Section 23 - Glossary and definitions of our Q2-2022 MD&A, as well as in the glossary available in the "Investors" section of our web site at www.intactfc.com.
- Certain totals, subtotals and percentages may not agree due to rounding. Not meaningful (nm) is used to indicate that the current and prior year figures are not comparable, not meaningful, or if the percentage change exceeds 1,000%.
Chief Executive Officer
Page 5 | Q2-2022 Review of Performance
Key points & highlights
|
|
|
90.7% |
|
NOIPS1 |
EPS |
Operating Combined Ratio1 |
|
with meaningful accretion from RSA and strong |
increased 85%, reflecting strong operating results |
with all segments delivering operating combined ratios in the low-90s. |
|
significant gains on investments and the sale of |
||
|
investment and underwriting results |
||
|
Codan Denmark |
||
|
+36% |
constant |
+41% |
|
|
currency |
|||
|
Operating DPW Growth1 |
DPW Growth |
BVPS |
|
|
driven by the RSA acquisition and organic |
increased by 4% y-o-y, as strong earnings were offset in part by mark-to- |
||
|
as reported under IFRS |
market losses on our investments caused by the increase in interest rates |
||
|
growth of 4% |
|||
|
and recent volatility in capital markets |
|||
|
15.4% |
18.5% |
|
|
OROE1 |
ROE1 |
Total Capital Margin2 |
|
reflecting robust operating and non-operating performance |
Strong financial position and solid regulated capital ratios in all |
|
jurisdictions, despite volatile capital markets |
|
1This is a non-GAAP measure. See section 19 - Non-GAAPand other financial measures of the Q2-2022 MD&A, available on www.sedar.com.
2 See section 17.2 - Maintaining a strong capital position of the Q2-2022 MD&A, available on www.sedar.com
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Disclaimer



Consumer Watchdog Challenges $202 Million Auto Club Insurance Rate Increase & Job-Based Insurance Rate Discrimination
Demand For The Usage-Based Insurance Market Is Being Driven By The Expansion Of The Global Automobile Sector
Advisor News
- Wall Street CEOs warn Trump: Stop attacking the Fed and credit card industry
- Americans have ambitious financial resolutions for 2026
- FSI announces 2026 board of directors and executive committee members
- Tax implications under the One Big Beautiful Bill Act
- FPA launches FPAi Authority to support members with AI education and tools
More Advisor NewsAnnuity News
- Retirees drive demand for pension-like income amid $4T savings gap
- Reframing lifetime income as an essential part of retirement planning
- Integrity adds further scale with blockbuster acquisition of AIMCOR
- MetLife Declares First Quarter 2026 Common Stock Dividend
- Using annuities as a legacy tool: The ROP feature
More Annuity NewsHealth/Employee Benefits News
- Illinois extends enrollment deadline for health insurance plans beginning Feb. 1
- Virginia Republicans split over extending health care subsidies
- Illinois uses state-run ACA exchange to extend deadline
- Fewer Americans sign up for Affordable Care Act health insurance as costs spike
- Deerhold and Windsor Strategy Partners Launch Solution that Enhances Network Analysis for Stop-Loss Carriers and MGUs
More Health/Employee Benefits NewsLife Insurance News